论文部分内容阅读
以往报道表明对二次探查术(SLL)阳性卵巢癌患者实行再次减灭术加P~(32)或全腹腔放疗(WART)等辅助治疗可改善生存率,为了通过大样本队列分析和长期随访以明确其是否能改善生存率,对1977～1989年150例SLL阳性卵巢癌患者进行回顾性分析,记录相关的临床资料。据手术前后病变范围分6组;SLL前SLL后镜下病变,SLL前≤1cm/SLL后镜下病变,SLL前≤1cm/SLL后≤1cm,SLL前>1cm/SLL后镜下
Previous reports have shown that secondary revascularization (SLL) -positive ovarian cancer patients with adjuvant subtraction and P ~ (32) or the whole abdominal radiotherapy (WART) and other adjuvant therapy can improve survival, in order to pass a large sample cohort analysis and long-term follow-up To determine whether it can improve the survival rate, from 1977 to 1989, 150 cases of SLL-positive ovarian cancer patients were retrospectively analyzed, the relevant clinical data were recorded. According to the scope of the preoperative and postoperative lesions in 6 groups; SLL before and after SLL lesions, SLL ≤ 1cm / SLL before the endoscopic lesions, SLL ≤ 1cm / SLL ≤ 1cm, SLL> 1cm / SLL before